Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A8EU
|
|||
| Former ID |
DNC004097
|
|||
| Drug Name |
(4R)-4-ammoniopentanoate
|
|||
| Synonyms |
(R)-4-Aminopentanoic acid; 4R-aminopentanoic acid; 5937-83-7; UNII-UPX83HFN1B; UPX83HFN1B; (4R)-4-aminopentanoic acid; (R)-(+)-4-Aminovaleric acid; (4R)-4-ammoniopentanoate; AC1L9GD1; 4-Aminovaleric acid, (R)-; CHEMBL281098; SCHEMBL15177649; Pentanoic acid, 4-amino-, (R)-; ZINC1706201; Pentanoic acid, 4-amino-, (4R)-; LMFA01100021; AKOS006337463; Valeric acid, 4-amino-, (R)-(+)-; UNII-CDM626IVRT component ABSTXSZPGHDTAF-SCSAIBSYSA-N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H11NO2
|
|||
| Canonical SMILES |
CC(CCC(=O)O)N
|
|||
| InChI |
1S/C5H11NO2/c1-4(6)2-3-5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m1/s1
|
|||
| InChIKey |
ABSTXSZPGHDTAF-SCSAIBSYSA-N
|
|||
| CAS Number |
CAS 5937-83-7
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GABA(A) receptor alpha-1 (GABRA1) | Target Info | Inhibitor | [1] |
| GABA(A) receptor alpha-2 (GABRA2) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor alpha-3 (GABRA3) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor alpha-5 (GABRA5) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor beta-2 (GABRB2) | Target Info | Inhibitor | [1] | |
| GABA(A) receptor gamma-2 (GABRG2) | Target Info | Inhibitor | [1] | |
| Gamma-aminobutyric acid receptor (GAR) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Retrograde endocannabinoid signaling | ||||
| Serotonergic synapse | ||||
| GABAergic synapse | ||||
| Morphine addiction | ||||
| Nicotine addiction | ||||
| Reactome | Ligand-gated ion channel transport | |||
| GABA A receptor activation | ||||
| WikiPathways | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||
| Iron uptake and transport | ||||
| SIDS Susceptibility Pathways | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. J Med Chem. 1981 Dec;24(12):1377-83. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.